Kolexia
El Mahmoud Rami
Cardiologie
Clinique Chirurgicale Du Val D Or
Saint-Cloud, France
71 Activités
612 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Cardiomyopathies Syndrome de tako-tsubo Syndrome coronarien aigu Hémorragie Maladie des artères coronaires Ischémie myocardique Spasme coronaire Spasme Entorses et foulures

Industries

AstraZeneca
2 collaboration(s)
Dernière en 2020
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

SENIOR: Efficacy and Safety of New Generation Drug Eluting Stents Associated With an Ultra Short Duration of Dual Antiplatelet Therapy. Design of the Short Duration of Dual antiplatElet Therapy With SyNergy II Stent in Patients Older Than 75 Years Undergoing Percutaneous Coronary Revascularization.
Essai Clinique (Ceric Sàrl)   11 janvier 2024
Clinical Outcomes in Patients Treated With Biodegradable-Polymer Biolimus-Eluting Stents and 6 Months of Dual-Antiplatelet Therapy: The French eBiomatrix 6-Month DAPT Registry.
The Journal of invasive cardiology   22 avril 2022
Bleeding in the Elderly: Risk Factors and Impact on Clinical Outcomes After an Acute Coronary Syndrome, a Sub-study of the Randomized ANTARCTIC Trial.
American journal of cardiovascular drugs : drugs, devices, and other interventions   30 juin 2021
Two-year outcomes after percutaneous coronary intervention with drug-eluting stents or bare-metal stents in elderly patients with coronary artery disease.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions   06 août 2020
Impact and predictive factors of bleeding complications in elderly patients admitted for an acute coronary syndrome: Insights from the ANTARCTIC trial
Les 29èmes Journées Européennes de la Société Française de Cardiologie   01 janvier 2019
Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial.
Lancet (London, England)   01 novembre 2017
Bivalirudin infusion to reduce ventricular infarction: the open-label, randomised Bivalirudin Infusion for Ventricular InfArction Limitation (BIVAL) study.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology   04 août 2017
ANTARCTIC: The ANTARCTIC Study - Assessment of a Normal Versus Tailored Dose of Prasugrel After Stenting in Patients Aged > 75 Years to Reduce the Composite of Bleeding, Stent Thrombosis and Ischemic Complications
Essai Clinique (Lilly)   10 janvier 2017
Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial.
Lancet (London, England)   28 août 2016
Incidence, Characteristics, Risk Factors, and Outcomes of Takotsubo Cardiomyopathy With and Without Ventricular Arrhythmia.
The American journal of cardiology   28 janvier 2016